Brief: Active Biotech To Present Positive LION Studies Results In Orlando
10/09/2025 12:12
Sept 10 (Reuters) - Active Biotech AB publ ACTI.ST: POSITIVE RESULTS FROM ACTIVE BIOTECH’S CLINICAL PHASE I LION STUDY TO BE PRESENTED AT AAO 2025 IN OCTOBER Source text: ID:nMFN1kn1JV Further company coverage: ACTI.ST (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million